Syncor International to Invest in New Product

Syncor International Corp. said it will make a $14-million investment in the development and distribution of a new type of diagnostic tool for detecting lung and breast cancer over the next three years.

The product, called positron emission tomography, is an extension of the kind of radio-pharmaceutical product the company already sells. Syncor expects to set up 24 distribution centers for it nationwide.